deltatrials
Unknown OBSERVATIONAL NCT04445532

Hepatobiliary Tumors Tissue Samples Acquisition

Acquisition of Blood and Tumor Tissue Samples From Patients With Hepatobiliary Tumors

Sponsor: GeneCast Biotechnology Co., Ltd.

Conditions Benign Hepatobiliary Disease Biliary Tract Cancer Cholangiocarcinoma Gallbladder Cancer Healthy, no Evidence of Disease Hepatocellular Carcinoma Liver Cancer Precancerous Condition
Interventions Gene expression analysis Genomic analysis Immunohistochemistry Laboratory biomarker analysis Liquid biopsy analysis Mass spectrometry Metabolomics profiling Methylation and epigenetic analysis Polymerase chain reaction Protein expression analysis Proteomic profiling
Updated 12 times since 2020 Last updated: Jul 5, 2023 Started: Oct 11, 2020 Primary completion: Jun 1, 2025 Completion: Jun 1, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Benign Hepatobiliary Disease and Biliary Tract Cancer and is currently ongoing. GeneCast Biotechnology Co., Ltd. leads this study, which shows 12 recorded versions since 2020 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jul 2020 – ~Nov 2020 · 4 months · monthly snapshotNot Yet Recruiting~Nov 2020 – ~Dec 2020 · 30 days · monthly snapshotNot Yet Recruiting~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshotRecruiting~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotRecruiting~Oct 2021 – ~Dec 2021 · 2 months · monthly snapshotRecruiting~Dec 2021 – ~Jul 2022 · 7 months · monthly snapshotRecruiting~Jul 2022 – ~Apr 2023 · 9 months · monthly snapshotRecruiting~Apr 2023 – ~Aug 2023 · 4 months · monthly snapshotRecruiting~Aug 2023 – ~Jul 2024 · 11 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – ~Jul 2025 · 10 months · monthly snapshotRecruiting~Jul 2025 – present · 12 months · monthly snapshotUnknown

Change History

12 versions recorded

  1. Jul 2025 — Present [monthly]

    Unknown

    Status: Recruiting → Unknown

  2. Sep 2024 — Jul 2025 [monthly]

    Recruiting

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  4. Aug 2023 — Jul 2024 [monthly]

    Recruiting

  5. Apr 2023 — Aug 2023 [monthly]

    Recruiting

▶ Show 7 earlier versions

  1. Jul 2022 — Apr 2023 [monthly]

    Recruiting

  2. Dec 2021 — Jul 2022 [monthly]

    Recruiting

  3. Oct 2021 — Dec 2021 [monthly]

    Recruiting

  4. Jan 2021 — Oct 2021 [monthly]

    Recruiting

  5. Dec 2020 — Jan 2021 [monthly]

    Recruiting

    Status: Not Yet Recruiting → Recruiting

  6. Nov 2020 — Dec 2020 [monthly]

    Not Yet Recruiting

  7. Jul 2020 — Nov 2020 [monthly]

    Not Yet Recruiting

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • GeneCast Biotechnology Co., Ltd.
  • Geneplus-Beijing Co. Ltd.
  • OrigiMed
  • Peking Union Medical College Hospital
  • YuceBio Technology Co., Ltd.
Data source: Peking Union Medical College Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations